NCT02922036Active, not recruitingNot Applicable
Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders, Previously Untreatable and High Risk Upgrade Patients (SOLVE CRT)
EBR Systems, Inc.127 sites in 2 countries300 target enrollmentStarted: January 17, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- EBR Systems, Inc.
- Enrollment
- 300
- Locations
- 127
- Primary Endpoint
- Primary Efficacy 1
Study Overview
Brief Summary
This study is a prospective, multi-center, pivotal trial to study the safety and efficacy of the WiSE-CRT System for Cardiac Re-synchronization Therapy.
Detailed Description
The WiSE-CRT System is an implantable cardiac pacing system capable of delivering pacing energy to the left ventricle of the heart without using a pacing lead.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Sequential
- Primary Purpose
- Treatment
- Masking
- None
Masking Description
One part of the study was randomized. The final part of the study was single-arm, open label.
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Primary Efficacy 1
Time Frame: 6 Months
Mean relative % change in Left Ventricular End Systolic Volume (LVESV) baseline to 6 Months.
Primary Safety
Time Frame: 6 Months
Freedom from Procedure and Device System related Type 1 Complications
Secondary Outcomes
- Secondary Efficacy 2(6 Months)
- Secondary Efficacy 5(6 months)
- Secondary Efficacy 3(6 months)
- Secondary Efficacy 1(6 Months)
- Secondary Efficacy 4(6 months)
Investigators
Study Sites (127)
Loading locations...
Similar Trials
Completed
Not Applicable
Wireless Stimulation Endocardially for Cardiac Resynchronization TherapyVentricular DysfunctionHeart FailureCardiomyopathyNCT01294527EBR Systems, Inc.17
Completed
Not Applicable
Safety and Effectiveness Study of the Solysafe Septal OccluderAtrial Septal DefectsNCT00353509Carag AG
Completed
Not Applicable
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE TrialChronic Heart FailureNCT01166347Medtronic Cardiac Rhythm and Heart Failure451
Active, not recruiting
Not Applicable
Swedish Evaluation of Left Ventricular Assist Device as Permanent Treatment in End-stage Heart FailureEnd-stage Heart FailureNCT02592499Vastra Gotaland Region74
Completed
Not Applicable
A Trial of Rehabilitation Paired With VNS for Motor Function in Patients With Stroke (Repair Study)Ischemic StrokeUpper Extremity ParesisNCT06722677Beijing Pins Medical Co., Ltd99
